J Gynecol Oncol.  2014 Oct;25(4):265-266. 10.3802/jgo.2014.25.4.265.

Human papillomavirus: wearisome or awesome issue?

• Cho NH

• KMID: 2130110
• DOI: http://doi.org/10.3802/jgo.2014.25.4.265

Abstract

No abstract available.

MeSH Terms

Cervical Intraepithelial Neoplasia/*diagnosis
Female
Human Papillomavirus DNA Tests/*methods
Humans
Papillomavirus Infections/*diagnosis
Uterine Cervical Neoplasms/*diagnosis

Reference

1. Guo Y, You K, Geng L, Qiao J. The clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologies. J Gynecol Oncol. 2014; 25:287–292.

2. Discacciati MG, da Silva ID, Villa LL, Reis L, Hayashi P, Costa MC, et al. Prognostic value of DNA and mRNA e6/e7 of human papillomavirus in the evolution of cervical intraepithelial neoplasia grade 2. Biomark Insights. 2014; 9:15–22.

3. Matovina M, Sabol I, Grubisic G, Gasperov NM, Grce M. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol Oncol. 2009; 113:120–127.

4. Jones DL, Alani RM, Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 1997; 11:2101–2111.

5. Horikawa I, Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis. 2003; 24:1167–1176.

6. Nguyen ML, Nguyen MM, Lee D, Griep AE, Lambert PF. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J Virol. 2003; 77:6957–6964.